From strains to sprains and more, the vast majority of sports related injuries respond well with non-surgical care.
That is why it is always the first approach at NJOI. The NJOI orthopaedists, and in particular its primary care physicians specializing in sports medicine, offer a variety of non-surgical services for musculoskeletal care. NJOIs vast experience with athletes of all ages and levels emphasizes both injury care and prevention with these services.
Nonsteroidal anti-inflammatory drugs (NSAIDs) include aspirin, ibuprofen (e.g., Advil), naproxen (e.g., Aleve) and nabumetone (e.g., Relafen). These medications address an injury by helping reduce pain and inflammation. However, they can have negative effects if used improperly and it is important than the experts at NJOI assess and recommend these medications for each individual so that they can be taken safely and effectively.
NJOI also offers various injections, including cortisone. These injections are designed to help with chronic, painful inflammation. Delivering cortisone by injection provides very high concentrations of the medication directly to the affected area, while minimizing potential side effects. These injections usually work within a few days, and the effects can last up to several weeks and sometimes even permanently.
Its extensive sports medicine experience means NJOI can provide all of its patients with the best advice for an athletic or active lifestyle. This includes such important areas as strength training and conditioning, flexibility exercises, sports nutrition, and concussion management.
While taping and bracing should not be used in place of personalized medical care when indicated (such as for ongoing pain or serious injury), nor as a substitute for important rehabilitation exercises, these methods can provide extra support for joint instability or for rehabilitating injuries. Both taping and bracing are a common feature of all sports participation. The experts at NJOI understand the concepts and techniques of these methods, and are particularly experienced due to their numerous positions as youth, collegiate and professional sports team physicians.
Platelet-rich plasma (PRP) has become a treatment option for a wide variety of athletes, from recreational to avid amateurs to professionals. This procedure is particularly useful for persistent partial tendon problems, such as tennis elbow, plantar fasciitis, quadriceps and patellar tendon tears; partial muscle tears and ligament tears as well as utilized in conjunction with surgical procedures to increase the chances of healing. While its success rate may vary, PRP holds out hope as a non-invasive potential solution to healing.
In addition to its plasma component, blood also contains red and white cells, as well as platelets. Besides their role in clotting blood, platelets also contain healing properties due to their growth factors (which are the proteins in the blood). For PRP, blood is drawn from the patients. The platelets are separated in a centrifuge process, increasing their concentration from 5 to 10 times greater than normal. They are then combined with the remaining blood and injected into injured tissues in order to facilitate more rapid healing. PRP is a non-surgical treatment, and the risks of PRP are minimal.
Among the ranks of those who have been treated with PRP are professional athletes, like Tiger Woods, Kobe Bryant and Rafael Nadal, as well as two injured NFL players before winning a Super Bowl. Countless weekend warriors have also found relief through this treatment.
While much publicity surrounds use of PRP for athletes, the procedure actually began in the 1990s in connection with plastic surgery. At NJOI, we use PRP for a variety of conditions. A number of studies have demonstrated that PRP injections have lessened pain and improved function in joints, including the elbow, wrist, shoulder, hip, knee, and ankle.
In separate trials done in 2011, PRP lowered blood loss in 81 patients with knee replacements, and lessened pain for 21 with tennis elbow.* *http://www.bloomberg.com/news/2012-08-24/blood-therapy-used-by-tiger-woods-lures-everyday-athletes.html
Over a million U.S. patients have been treated with stem cells in the past decade and a half. Currently, there are over 70 proven therapies using adult stem cells. Stem cell therapy at NJOI, done via ultrasound guidance, has the potential to help accelerate healing in tendon/ligament injuries, and to augment the sub-optimal healing from other techniques or surgeries.
The process of receiving stem cell therapy starts with harvesting your own stem cells from the bone marrow. Stem cells are harvested from the iliac crest (hip bone) using AN anesthetic and a special small biopsy needle. These stem cells- called Mesenchymal Stem Cells (MSC)- areautologous, meaning they are the patients own stem cells.
Harvesting MSCs for injection therapy is done in our office and only takes a short amount of time.The skin and hip bone are numbed. A special needle is then passed through the cortex of the bone into the marrow cavity. This is apainlessprocedure in most cases.The liquid marrow is then very slowly drawn into a syringe.
Then your bone marrow gets spun in a centrifuge for 15 minutes allowing the undifferentiated mesenchymal stem cells to separate from the platelets and blood. Our experienced surgeon will then inject your own stem cells into the joint or damaged tissue.
These mesenchymal stem cells have the ability to turn into cartilage, ligament, tendon, bone, nerve tissue, blood vessels, or muscle tissue. These cells find the area of damage, connect to your DNA and determine the code that tells them into what to reproduce. Stem cells can only grow the same tissue you would have had before the damage.
This procedure is particularly useful for persistent partial tendon tears, such as tennis elbow, plantar fasciitis, quadriceps and patellar tendon tears; partial muscle tears; meniscus tears in the knee and chondromalacia patella (patellofemoral syndrome).
Arthritis afflicts about 50 million people of all ages throughout the country. Osteoarthritis is the most common form of this disease, characterized by deteriorated cartilage surrounding the joints. Healthy cartilage serves to cushion and protect the bones in joints preventing friction and allowing for fluid movement.
Viscosupplementation is a minimally invasive, therapeutic treatment for those who have not seen improvements through medication or other traditional treatments. Hyaluronic acid, a naturally occurring gel-like substance found in the synovial fluid of the joints, is injected into the affected joint and acts as a lubricant. Individuals with osteoarthritis typically have less of this naturally occurring acid, so the treatment works to supplement for the lack of fluid. Viscosupplementation at NJOI is primarily used on the knee, but can also be done on the hip or shoulder.
Read the original post:
Non-Surgical - The New Jersey Orthopaedic Institute
- Latest Insights on Stem Cell Assay Market Business Strategies, Acquisitions, Revenue Analysis Share, Forecast to 2028 | by Perkinelmer Inc, Promega... - October 13th, 2022
- S.I. school hosts dance-a-thon to support 9-year-old student with sickle cell disease - SILive.com - October 13th, 2022
- Cord blood bank - Wikipedia - October 4th, 2022
- Cell Reprogramming Market is Expected to Record the Massive Growth, with Prominent Key Players Allele Biotechnology, ALSTEM, Applied Biological... - September 16th, 2022
- Pleco Therapeutics Announces Final Close of its Series A Financing Raising 17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to... - September 8th, 2022
- Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates - KULR-TV - August 14th, 2022
- Cell Expansion Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 Shanghaiist - Shanghaiist - August 5th, 2022
- 3D Bioprinting for Tissue and Organ Regeneration Market worth $424.3 Million by 2030 - Exclusive Report by InsightAce Analytic - Yahoo Finance - July 27th, 2022
- After conquering sickle cell and multiple sclerosis, it was COVID-19 that claimed her - Lynchburg News and Advance - July 11th, 2022
- Stem Cell Therapy Market to Observe Exponential Growth By 2022 to 2030 | Smith, Nephew (UK), MEDIPOST Co Ltd. (South Korea) - Digital Journal - June 22nd, 2022
- Teclison Announces Publication of Phase 1 Data Demonstrating the Safety and Therapeutic Potential of Tirapazamine Chemoembolization for Patients with... - June 22nd, 2022
- This Key Protein Is Essential for Brain Cell Longevity and Growth - SciTechDaily - June 13th, 2022
- Stem Cell Cartilage Regeneration Market to Witness Massive Growth from 2022 to 2030 | Central members covered as a piece of this study incorporate... - June 13th, 2022
- Stem Cell Therapy Market Size, Scope and Forecast | Osiris Therapeutics Medipost Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd.,... - June 4th, 2022
- Advanced Therapy Medicinal Products (ATMP) Service Providers Market worth $34.59 Billion by 2030 - Exclusive Report by InsightAce Analytic - Yahoo... - June 4th, 2022
- Gene Therapy Market Size, Scope and Forecast | Novartis AG, Biogen, Gilead Sciences MolMed SpA, Spark Therapeutics Orchard Therapeutics plc., SIBIONO,... - June 4th, 2022
- Cell Isolation/Cell Separation Market Size, Scope and Forecast | Beckman Coulter (Subsidiary of Danaher Corporation), Becton, Dickinson and Company,... - June 4th, 2022
- 8 Players Leading the 3D Printed Meat Revolution - 3DPrint.com - May 2nd, 2022
- Penn researchers discover new cell type in human lung with regenerative properties - EurekAlert - April 6th, 2022
- FDA Grants Fast Track Designation to CYNK-001 for AML Treatment - Targeted Oncology - January 5th, 2022
- Stem Cell Therapy: a Look at Current Research, Regulations ... - December 24th, 2021
- Stem Cells Market to Witness Gigantic Growth by 2026 LSMedia - LSMedia - December 24th, 2021
- Peaceful Protest at Cherry Hill Women's Center Warning Public of Increase in Late Term Abortions In New Jersey. - InsiderNJ - October 16th, 2021
- Time to Go Sushi With Cellular Salmon; When Pet Owners Tire of Their Minions - The SandPaper - August 18th, 2021
- Avalon GloboCare, UPMC Hillman and University of Pittsburgh to develop new cancer immunotherapy - Proactive Investors USA & Canada - August 5th, 2021
- John Theurer Cancer Center Investigators Participated in ZUMA-7 Study Showing Value of CAR T-Cell Therapy as Second-Line Treatment for Relapsed Large... - July 21st, 2021
- ExoFlo From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment - PRNewswire - July 21st, 2021
- GXGX Merger: The SPAC News That Has GXGX Stock Soaring - InvestorPlace - July 21st, 2021
- This Startup is Changing the Way Spinal Cord Injury Is Treated Around the World - Entrepreneur - June 23rd, 2021
- Genmab Announces that Janssen has Received European - GlobeNewswire - June 23rd, 2021
- Gene therapy offers potential cure to children born without an immune system - UCLA Newsroom - May 13th, 2021
- Commencement stories from Rowan paint a picture of opportunities near and far - NJ.com - May 13th, 2021
- Vitalant to Hold Blood Donation Event on December 5 in Freehold - TAPinto.net - December 1st, 2020
- Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn - GlobeNewswire - October 23rd, 2020
- Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratumumab in Multiple Myeloma... - October 23rd, 2020
- Novel Strategies for Targeting the Guardian of the Genome Emerge - OncLive - October 23rd, 2020
- CRISPR Market to See Massive Growth by 2026 | GE Healthcare Dharmacon, CRISPR Therapeutics, Thermo Fisher Scientific - Aerospace Journal - October 23rd, 2020
- Smith's 2005 stem cell law to be reauthorized by House - InsiderNJ - October 4th, 2020
- Oakland 24-year-old seeking multiethnic bone marrow donor - The Jewish News of Northern California - September 21st, 2020
- 99-million-year-old fight between hell ant and its prey preserved in amber - BBC Focus Magazine - August 12th, 2020
- Vitalant to Hold Blood Donation Drive on August 11 in Atlantic Highlands - TAPinto.net - August 12th, 2020
- Stem Cells Sales Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News - July 7th, 2020
- Mesenchymal Stem Cells Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News - July 7th, 2020
- Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 Break Down by Top Companies, Countries, Applications, Challenges,... - June 10th, 2020
- Stem Cells Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty - June 10th, 2020
- Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX (daratumumab) for the Treatment of Patients with... - June 10th, 2020
- CO2 Incubators Market is Expected to Witness a Steady Growth by 2025 - Farmers Ledger - June 4th, 2020
- Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with... - May 13th, 2020
- Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), for the Treatment... - May 6th, 2020
- CO2 Incubators Market Update: Uncover the Business Strategies of Leaders & Laggards of the Market - 3rd Watch News - March 6th, 2020
- SpaceX set to launch Falcon 9 rocket and Dragon capsule from Cape Canaveral this week - Florida Today - March 4th, 2020
- Are stem cells really the key to making humans live longer? - Wired.co.uk - February 16th, 2020
- Musicians and community coming together in Asbury Park to help Point Pleasant 3-year old - Asbury Park Press - February 12th, 2020
- TV Guy: A return to history with Auschwitz Untold - New Jersey Herald - January 27th, 2020
- Europe's guardian of stem cells and hopes, real and unrealistic - FRANCE 24 - January 20th, 2020
- Horizon Discovery to Provide Access to Novel Base Editing Technology - Yahoo Finance - January 15th, 2020
- John Theurer Cancer Center Announces Appointment of Five New Physicians - Newswise - January 15th, 2020
- Horizon to provide access to novel base editing technology - SelectScience - January 15th, 2020
- Reviewing Phibro Animal Health (NASDAQ:PAHC) & AgeX Therapeutics (NASDAQ:AGE) - Riverton Roll - January 15th, 2020
- Stemming the Tide Confronting Anti-Semitism in the 21st Century - The Times of Israel - January 5th, 2020
- Weekly pick of Neuroscience news from around the world - Brain Tumour Research - November 30th, 2019
- Comparing of Rigel Pharmaceuticals Inc. (RIGL) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - The Broch Herald - November 28th, 2019
- Celgene to Present New and Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annual Meeting - Business... - November 6th, 2019
- Reviewing Surface Oncology Inc. (SURF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury - November 6th, 2019
- Reviewing Magenta Therapeutics Inc. (MGTA)'s and PTC Therapeutics Inc. (NASDAQ:PTCT)'s results - FinanceMercury - November 6th, 2019
- Reviewing Capricor Therapeutics Inc. (CAPR)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - FinanceMercury - November 6th, 2019
- Live Cell Imaging Consumables Market Evolving to a Next-Generation Strategy with New Partnerships, Technologies and Targets by 2023 key players LCC... - November 6th, 2019
- Contrasting of Spero Therapeutics Inc. (SPRO) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - FinanceMercury - November 6th, 2019
- PTC Therapeutics Inc. (PTCT) and Jounce Therapeutics Inc. (NASDAQ:JNCE) Comparing side by side - FinanceMercury - November 6th, 2019
- Contrasting of Brainstorm Cell Therapeutics Inc. (BCLI) and HOOKIPA Pharma Inc. (NASDAQ:HOOK) - MS Wkly - November 2nd, 2019
- Reviewing Brainstorm Cell Therapeutics Inc. (BCLI)'s and Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)'s results - MS Wkly - November 2nd, 2019
- Reviewing ImmunoGen Inc. (IMGN)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - November 2nd, 2019
- On Stage: Allegaeon ready to rock Philly - The Unionville Times - November 2nd, 2019
- Comparison of Merus N.V. (MRUS) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly - October 14th, 2019
- Reviewing Curis Inc. (CRIS)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 14th, 2019
- Comparing of NewLink Genetics Corporation (NLNK) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly - October 14th, 2019
- Reviewing Morphic Holding Inc. (MORF)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 14th, 2019
- Reviewing PTC Therapeutics Inc. (PTCT)'s and Inovio Pharmaceuticals Inc. (NASDAQ:INO)'s results - MS Wkly - October 14th, 2019
- Comparing of Osmotica Pharmaceuticals plc (OSMT) and VistaGen Therapeutics Inc. (NASDAQ:VTGN) - MS Wkly - October 14th, 2019
- PTC Therapeutics Inc. (PTCT) and MacroGenics Inc. (NASDAQ:MGNX) Comparing side by side - MS Wkly - October 14th, 2019